Julie Krop

2018

In 2018, Julie Krop earned a total compensation of $1.6M as Chief Medical Officer and Executive Vice President, Clinical and Regulatory Affairs at AMAG Pharmaceuticals, a 28% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$305,800
Option Awards$235,807
Salary$471,139
Stock Awards$607,320
Other$11,000
Total$1,631,066

Krop received $607.3K in stock awards, accounting for 37% of the total pay in 2018.

Krop also received $305.8K in non-equity incentive plan, $235.8K in option awards, $471.1K in salary and $11K in other compensation.

Rankings

In 2018, Julie Krop's compensation ranked 6,749th out of 14,244 executives tracked by ExecPay. In other words, Krop earned more than 52.6% of executives.

ClassificationRankingPercentile
All
6,749
out of 14,244
53rd
Division
Manufacturing
2,577
out of 5,759
55th
Major group
Chemicals And Allied Products
966
out of 2,122
55th
Industry group
Drugs
811
out of 1,811
55th
Industry
Pharmaceutical Preparations
632
out of 1,385
54th

Pay ratio

Julie Krop's Pay$1,631,066
Median Employee's Pay$195,142
Pay Ratio

8

to 1

In 2018, the annual total compensation of Julie Krop was $1,631,066.

The annual total compensation of the median employee at AMAG Pharmaceuticals was $195,142.

The ratio of Julie Krop's pay to the pay of median employee was therefore 8 to one.

Source: SEC filing on April 12, 2019.

Krop's colleagues

We found five more compensation records of executives who worked with Julie Krop at AMAG Pharmaceuticals in 2018.

2018

William Heiden

AMAG Pharmaceuticals

Chief Executive Officer

2018

J Butcher

AMAG Pharmaceuticals

Chief Business Officer and Executive Vice President

2018

Nicholas Grund

AMAG Pharmaceuticals

Former Chief Commercial Officer

2018

Edward Myles

AMAG Pharmaceuticals

Chief Financial Officer

2018

Joseph Vittiglio

AMAG Pharmaceuticals

General Counsel

News

You may also like